Capital Stock	9 Months Ended
Sep. 30, 2025
Equity [Abstract]
Capital Stock [Text Block]	13. Capital Stock As at September 30, 2025, the Company had 150,000,000 common shares authorized with a par value of $.0001 per share and 142,332,019 (December 31, 2024-131,332,019) common shares issued and outstanding. During the three and nine-month periods ended September 30, 2025, the Company raised $nil and $220,000 (2024-$120,000 and $120,000) respectively, in three private placements (2024-one private placement) for the issuance of a total of 11,000,000 (2024-6,000,000) common shares to Travellers, at a price of $0.02 per share. During the three and nine-month periods ended September 30, 2025, Travellers converted a total of $nil (C$nil) and $nil (C$nil) (2024-$nil; C$nil and $101,130; C$135,600) of outstanding accounts payable owing to Travellers for nil (2024 - 809,044) common shares of the Company at the closing trading price immediately prior to the conversion. There was no gain or loss on this conversion. In addition, on March 18, 2024, the Company submitted a cancellation order to its transfer agent to cancel 750,000 common shares issued in the prior year to a consultant. There was no gain or loss on this cancellation.

Capital Stock

9 Months Ended

Sep. 30, 2025

13. Capital Stock

As at September 30, 2025, the Company had 150,000,000 common shares authorized with a par value of $.0001 per share and 142,332,019 (December 31, 2024-131,332,019) common shares issued and outstanding.

During the three and nine-month periods ended September 30, 2025, the Company raised $nil and $220,000 (2024-$120,000 and $120,000) respectively, in three private placements (2024-one private placement) for the issuance of a total of 11,000,000 (2024-6,000,000) common shares to Travellers, at a price of $0.02 per share.

During the three and nine-month periods ended September 30, 2025, Travellers converted a total of $nil (C$nil) and $nil (C$nil) (2024-$nil; C$nil and $101,130; C$135,600) of outstanding accounts payable owing to Travellers for nil (2024 - 809,044) common shares of the Company at the closing trading price immediately prior to the conversion. There was no gain or loss on this conversion.

In addition, on March 18, 2024, the Company submitted a cancellation order to its transfer agent to cancel 750,000 common shares issued in the prior year to a consultant. There was no gain or loss on this cancellation.